SG/PUT/STRYKER CORP./250/0.1/21.03.25 Stock

Warrant

DE000SU6QVA2

Real-time Boerse Frankfurt Warrants 08:24:55 2024-06-24 EDT
0.22 EUR -18.52% Intraday chart for SG/PUT/STRYKER CORP./250/0.1/21.03.25
Current month-27.03%
1 month-35.71%
Date Price Change
24-06-24 0.22 -18.52%
24-06-21 0.27 0.00%
24-06-20 0.27 +42.11%
24-06-19 0.19 -29.63%
24-06-18 0.27 -6.90%

Real-time Boerse Frankfurt Warrants

Last update June 24, 2024 at 08:24 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SU6QVA
ISINDE000SU6QVA2
Date issued 2024-01-08
Strike 250 $
Maturity 2025-03-21 (270 Days)
Parity 10 : 1
Emission price 1.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.17
Spread 0.11
Spread %33.33%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
342.6 USD
Average target price
372.9 USD
Spread / Average Target
+8.84%
Consensus